Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$6.6 million.

  • Medifast's Free Cash Flow rose 833.79% to -$6.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 million, marking a year-over-year decrease of 9266.24%. This contributed to the annual value of $1.2 million for FY2025, which is 9266.24% down from last year.
  • Latest data reveals that Medifast reported Free Cash Flow of -$6.6 million as of Q4 2025, which was up 833.79% from $10.8 million recorded in Q3 2025.
  • Medifast's 5-year Free Cash Flow high stood at $61.9 million for Q1 2023, and its period low was -$19.1 million during Q4 2021.
  • Moreover, its 5-year median value for Free Cash Flow was $10.9 million (2024), whereas its average is $19.9 million.
  • As far as peak fluctuations go, Medifast's Free Cash Flow plummeted by 20724.4% in 2021, and later surged by 89109.22% in 2022.
  • Over the past 5 years, Medifast's Free Cash Flow (Quarter) stood at -$19.1 million in 2021, then surged by 323.63% to $42.7 million in 2022, then tumbled by 77.56% to $9.6 million in 2023, then tumbled by 175.52% to -$7.2 million in 2024, then increased by 8.34% to -$6.6 million in 2025.
  • Its Free Cash Flow was -$6.6 million in Q4 2025, compared to $10.8 million in Q3 2025 and -$4.8 million in Q2 2025.